medigraphic.com

2016, Número 3

<< Anterior Siguiente >>

Rev Med MD 2016; 7.8 (3)


Lupus eritematoso sistémico en paciente con miastenia gravis posterior a timectomía: Reporte de caso y revisión de la literatura

Navarro-Blackaller G, Martin-Nares E, Blanco-Ornelas LH, Flores-Alatorre G, Cárdenas-Saenz O, Ramírez-Ocho S, Zaragoza-Valdez DL, Cerpa-Cruz S

Idioma: Español
Referencias bibliográficas: 33
Paginas: 186-190
Archivo PDF: 540.01 Kb.


RESUMEN

La coexistencia de miastenia gravis y lupus eritematoso sistémico es poco común; aún más rara es la aparición de lupus eritematoso sistémico posterior a la realización de timectomía en una paciente con miastenia gravis. Se describe el caso de una paciente femenina de 21 años de edad conocida con diagnóstico de miastenia gravis, que 3 años posteriores a la realización de timectomía, presentó un cuadro de artritis poliarticular simétrica, eritema malar, alopecia, anemia hemolítica, linfopenia, hipocomplementemia, así como presencia de anticuerpos antinucleares, por lo que se integró el diagnóstico de lupus eritematoso sistémico. Se presenta además una revisión entre la asociación de timectomía y desarrollo de lupus eritematoso sistémico en pacientes con miastenia gravis, así como la descripción de otros casos reportados.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Alarcon Segovia D, Galbraith RF, Maldonado JE, Howard FM Jr. Systemic lupus er ythematosus following thymectomy for myasthenia gravis. Report of two cases. Lancet. 1963;2(7309):662–5.

  2. Mizon, J.P., Morcamp, D., Lefebvre, P., Froissart, M., Guidicelli, C.P. & Goasguen, J. Associated myasthenia and disseminated lupus erythematosus. A report on two patients and complete review of the published literature. Ann Med Intern 1979, 11: 489-500.

  3. Abbruzzese, G., Abbruzzese, M,. Bacigalupo, A et al. Systemic lupus erythematosus after thymectomy in a patient with myasthenia gravis. Neurology 1979, 29: 1436-1437.

  4. Calabrese, R.H., Bach, J.F., Currie, T. et al. Development of systemic lupus erythematosus after thymectomy for myasthenia gravis. Studies of suppressor cell function. Arch Intern Med 1981, 141: 253-255.

  5. Valesini, G., Pastore, R., De Bernandinis, P.G., Serafini, U., Vincent, A. & Bottazzo, G. F. Appearance of antiacetylcholine receptor antibodies coincident with onset of myasthenic weakness in patient with systemic lupus erythematosus. Lancet 1983, i: 831.

  6. Le Loet, X., Pouyol, F., Lees, 0. et al. Lupus erythemateaux aigu dissemine survenu apres thymectomie pour myasthenie. Etude sequentielle des sous populations lymphocytaires. Rev Med Intern 1986, 7: 425-432.

  7. Laukaitis, J.P. & Borenstein, D.G. Multiple autoinmune diseases in a predisposed patient. Arthritis Rheum 1989, 32: 119-120.

  8. Thorlacius, S., Aarli, J.A., Riise, T., Matre, R. & Johnsen, H.J. Associated disorders in myasthenia gravis: autoinmune diseases and their relation to thymectomy. Acta Neurol Scand 1989, 80: 290-295.

  9. Grinlinton, F.M., Lynch, N.M. & Hart, H.H. A pair of monozygotic twins who are concordant for myasthenia gravis but became discordant for systemic lupus erythematosus post-thymectomy. Arthritis Rheum 1991, 34: 916-919.

  10. Grinlinton, F.M., Lynch, N.M. & Hart, H.H. A pair of monozygotic twins who are concordant for myasthenia gravis but became discordant for systemic lupus erythematosus post-thymectomy. Arthritis Rheum 1991, 34: 916-919.

  11. G. Vaiopoulos. The association of systemic lupus erythematosus and myasthenia gravis. Postgrad Med J (1994) 70, 741 - 745.

  12. Mi-Jeong Park. Appearance of S y stemic Lupus Erythematosus in Patients with Myasthenia Gravis following Thymectomy: Two Case Reports. J Korean Med Sci 2004; 19: 134-6.

  13. Sumeet Bhinder, Vikas Majithia, Valee Harisdangkul. Myasthenia gravis and systemic lupus erythematosus: truly associated or coincidental-two case reports and review of the literature. Clin Rheumatol (2006) 25: 555-556.

  14. 13.Hyder A Omar. Systemic lupus erythematosus after thymectomy for myasthenia gravis: a case report and review of the literature. Clin Exp Nephrol (2010) 14:272-276.

  15. Shahar Shelly1. Thymoma and autoimmunity. Cellular & Molecular Immunology (2011) 8, 199-202.

  16. Can Ebru Bekircan-Kurt . The Course of Myasthenia Gravis with Systemic Lupus Er ythematosus. Eur Neurol 2014;72:326-329.

  17. 16.Aliona Nacu. Complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity 2015; 48(6): 362- 368.

  18. Chang-Fu Kuo, Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families. JAMA Intern Med. 2015;175(9):1518-1526. Referencias bibliográficas

  19. Cervera R, Piette J, Font J, Khamashta MA, Shoenfeld Y, Camps T, et al. Antiphospholipid Syndrome Clinical and Immunologic Manifestations and Patterns of Disease Expression in a Cohort of 1000 patients. Arthritis Rheum 2002;46(4):1019–27.

  20. Pinto-almeida T, Caetano M, Sanches M, Selores M. Cutaneous manifestations of antiphospholipid syndrome: A review of the clinical features, diagnosis and management. Acta Reumatol Port. 2013;10–8.

  21. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. England; 2006 Feb;4(2):295–306.

  22. Neill AO, Gatenby PA, Mcgaw B, Painter DM. Widespread cutaneous necrosis associated with cardiolipin antibodies. Journal of the American Academy of Dermatology 1990;356–9.

  23. Amster MS, Conway J, Zeid M, Pincus S. Cutaneous necrosis resulting from protein S deficiency and increased antiphospholipid antibody in a patient with systemic lupus erythematosus. J Am Acad Dermatol. American Academy of Dermatology, Inc.; 1993;29(5 Pt 2):853–7.

  24. Soweid AM, Hajjar RR, Hewan-Lowe KO, Gonzalez EB. Skin necrosis indicating antiphospholipid syndrome in patient with AIDS. South Med J. UNITED STATES; 1995 Jul;88(7):786–8.

  25. Jou I. Case Report Widespread Cutaneous Necrosis Associated with Antiphospholipid Syndrome. Clin Rheumatol. 1996 Jul;15(4):394-8.

  26. Fiehn C, Breitbart A, Germann G. Autologous skin transplantation for widespread cutaneous necrosis in secondary antiphospholipid syndrome. Ann Rheum Dis 2001;60:908–910.

  27. Creamer D, Hunt BJ, Black MM. Widespread cutaneous necrosis occurring in association with the antiphospholipid syndrome: A report of two cases. Br J Dermatol. 2000;142(6):1199–203.

  28. Rossini J, Roverano S, Graf C, Paira S. Widespread cutaneous necrosis associated with antiphospholipid antibodies: report of four cases. J Clin Rheumatol. 2002;8(6):326–31.

  29. DiFrancesco LM, Burkart P, Hoehn JG. A Cutaneous Manifestation of Antiphospholipid Antibody Syndrome. Ann Plast Surg. 2003;51(5):517–22.

  30. Costa R, Fazal S, Kaplan RB, Spero J, Costa R. Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis. Clin Rheumatol. 2013;32(SUPPL. 1):79–82.

  31. De Souza A, Capriglione ML, Fernandes J. Necrose cutanea extensa como primeira manifestacao da sindrome antifosfolipidica (SAF) secundaria. Acta Reumatologica Portuguese 2010;35:244-248.

  32. Aghdashi M, Aghdashi M, Rabiepoor M. Cutaneous necrosis of lower extremity as the fi rst manifestation of catastrophic antiphospholipid syndrome. Mod Rheumatol. 2015 May;25(3):490-2.

  33. Alegre VA, Gastineau DA, Winkelmann RK. Skin lesions associated with circulating lupus anticoagulant. Br J Dermatol. ENGLAND; 1989 Mar;120(3):419–29.




2020     |     www.medigraphic.com